Paper47018
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?
Padfield PL and 7 others. Lancet, 1975. Cited by 109 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Papers, record 47018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47018
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Renin | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Aldosterone | |
| Blood Pressure | |
| Blood Specimen Collection | |
| Female | |
| Humans | |
| Hypokalemia | |
| Male | |
| Middle Aged | |
| Photometry | |
| Potassium | |
| Sodium |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,832,907 | Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention. | Transl Psychiatry | 2012 | https://conductscience.org/library/papers/22832907 | PubMed |
| 22,493,079 | TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. | Hypertension | 2012 | https://conductscience.org/library/papers/22493079 | PubMed |
| 20,091,458 | Progress in primary aldosteronism: present challenges and perspectives. | Horm Metab Res | 2010 | https://conductscience.org/library/papers/20091458 | PubMed |
| 11,896,504 | Primary aldosteronism, a common entity? the myth persists. | J Hum Hypertens | 2002 | https://conductscience.org/library/papers/11896504 | PubMed |
| 6,993,778 | Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6993778 | PubMed |
| 2,954,611 | Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. | Br Med J (Clin Res Ed) | 1987 | https://conductscience.org/library/papers/2954611 | PubMed |
| 1,276,834 | Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension. | Br Med J | 1976 | https://conductscience.org/library/papers/1276834 | PubMed |
| 955,006 | Deficiency in renomedullary prostaglandin synthesis related to the evolution of essential hypertension. | Experientia | 1976 | https://conductscience.org/library/papers/955006 | PubMed |
| 837,134 | Angiotensin II in essential hypertension. | Br Med J | 1977 | https://conductscience.org/library/papers/837134 | PubMed |
| 766,908 | Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism. | Br Med J | 1976 | https://conductscience.org/library/papers/766908 | PubMed |
| 598,414 | Failure of methyclothiazide to lower home blood pressure level in "essential" hypertensive and normotensive young men, despite significant plasma volume contraction. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/598414 | PubMed |
| 510,240 | Age as a function in the development of sodium-related hypertension. | Environ Health Perspect | 1979 | https://conductscience.org/library/papers/510240 | PubMed |
| 449,254 | Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/449254 | PubMed |
| 366,278 | The renin-angiotensin-aldosterone system. Past, present and future. | Klin Wochenschr | 1978 | https://conductscience.org/library/papers/366278 | PubMed |
| 359,018 | Acebutolol in hypertension--double-blind trial against placebo. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/359018 | PubMed |
| 9,962 | Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect? | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/9962 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/47018
GET https://conductscience.org/api/papers/v1/47018/authors